DANIELLE TRAWEEK: Open Payments
NPI 1083398242 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 111 payments from 37 companies in 2025. Trend: 2023 $691 · 2024 $1,732 · 2025 $2,535
Food & beverage: $2,443Education: $92
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $274 |
| Daiichi Sankyo Inc. | 7 | $185 |
| Incyte Corporation | 10 | $173 |
| Exelixis Inc. | 3 | $143 |
| ABBVIE INC. | 5 | $141 |
| Stemline Therapeutics Inc. | 4 | $96 |
| Eisai Inc. | 4 | $95 |
| Astellas Pharma US Inc | 4 | $94 |
| Genentech USA, Inc. | 5 | $92 |
| Merck Sharp & Dohme LLC | 4 | $89 |
Products named: CABOMETYX, JAKAFI, Enhertu, ERLEADA, BRUKINSA, Orserdu, Lenvima, KEYTRUDA.
Industry payments across LA — which companies pay providers there.
